Caplin Point Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caplin Point Laboratories has sent a Postal Ballot notice to shareholders seeking approval for four board appointments via remote e-voting from January 2 to January 31, 2026. The resolutions include elevating Mr. Ashok Partheeban (son of Chairman C C Paarthipan) and Mr. Vivek Partheeban (another son of the Chairman) to the positions of Director and Vice-Chairman — both are existing Additional Directors since November 5, 2025. Mr. Vivek had stepped down as the company's Chief Operating Officer on November 5, 2025 to take up this board role. Additionally, Dr. K C John is being re-appointed as Non-Executive Independent Director for a five-year term (he had a prior tenure ending in August 2022), and Mrs. Susan Mathew, a retired IAS officer, is being appointed as Non-Executive Independent Director for five years from January 31, 2026. Mr. Ashok Partheeban holds 90.50 lakh equity shares in the company.
The induction of the Chairman's two sons as Vice-Chairmen signals a clear succession and promoter-family consolidation at the board level, which shareholders should weigh carefully. While the company is also strengthening its independent director bench with experienced profiles, the simultaneous exit of Mr. Vivek from the COO (KMP) role to a non-executive board position is a notable leadership change. The Postal Ballot outcome, due by January 31, 2026, will determine the formal board composition going forward.